首页> 外文期刊>Separation and Purification Technology >Removal of pharmaceutically active compounds (PhACs) from real membrane bioreactor (MBR) effluents by photocatalytic degradation using composite Ag2O/P-25 photocatalyst
【24h】

Removal of pharmaceutically active compounds (PhACs) from real membrane bioreactor (MBR) effluents by photocatalytic degradation using composite Ag2O/P-25 photocatalyst

机译:通过使用复合Ag2O / P-25光催化剂通过光催化降解从真实膜生物反应器(MBR)流出物中除去药物活性化合物(PHAC)

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmaceutically active compounds (PhACs) are emerging pollutants causing serious challenges to wastewater treatment plants due to poor biodegradability. In this study, the enhanced removal of highly recalcitrant and commonly monitored PhACs, carbamazepine (CBZ) and diclofenac (DCF) by heterogeneous photocatalysis was investigated using 5% Ag2O/P-25 photocatalyst. The photocatalyst was characterized by scanning electron microscope (SEM-EDX), Brunauer-Emmett-Teller (BET), Fourier transfer infrared spectroscopy (FTIR) and UV-vis diffuse reflectance spectra (UV-DRS). The effects of catalyst dose, initial pollutants concentration, and mineralization during the photocatalytic degradation of PhACs were investigated. The matrix effect was assessed in deionized water (DW) and real membrane bioreactor effluent (RME). Optimal CBZ and DCF removals of 89.10% and 93.5%, respectively for 180 min of UV irradiation were achieved at catalyst dosage of 0.4 g L-1 in DW matrix. However, the optimal catalyst dosages for CBZ and DCF in RME matrix were increased by factor 2 and 1.5, respectively, to achieve the same degree of removal. Declining trends of removal rate were observed when initial concentrations of both the PhACs were increased under optimal catalyst dosages, and kinetics seem to fit the Langmuir-Hinshelwood model. Photo-induced holes and (OH)-O-center dot were the dominant oxidation species involved in the photocatalytic degradation of the PhACs. A plausible reusability of 5% Ag2O/P-25 photocatalyst was observed for both the PhACs. Moreover, various aromatic/aliphatic intermediates generated during the photodegradation CBZ were identified using fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometry, and a possible multi-step degradation pathway was proposed. Overall, the removal of PhACs using 5% Ag2O/P-25 photocatalyst showed promising results in real wastewater.
机译:药学活性化合物(PHACs)是出现由于生物降解性差而导致废水处理厂的严重挑战。在该研究中,使用5%Ag 2 O / P-25光催化剂研究了通过异构光催化的高醋塑状和通常监测的PHAC,尿嘧啶(CBZ)和双氯酰芬酸(DCF)的增强去除。光催化剂的特征在于扫描电子显微镜(SEM-EDX),Brunauer-Emmett-Teller(Bet),傅里叶传输红外光谱(FTIR)和UV-VI扩散反射光谱(UV-DRS)。研究了催化剂剂量,初始污染物浓度和矿化期间PHACs光催化降解的影响。在去离子水(DW)和实际膜生物反应器流出物(RME)中评估基质效应。最佳CBZ和DCF除去89.10%和93.5%,分别在DW基质中的0.4g L-1的催化剂剂量下实现了180分钟的UV辐射。然而,RME基质中CBZ和DCF的最佳催化剂剂量分别增加因子2和1.5,以达到相同的去除程度。当在最佳催化剂剂量下初始浓度增加PHAC的初始浓度时,观察到去除率下降趋势,并且动力学似乎适合Langmuir-Hinshelwood模型。光诱导的孔和(OH)-O中心点是涉及PHACs光催化降解的主要氧化物种。为PHACS观察到5%Ag2O / P-25光催化剂的合理可重用性。此外,使用傅里叶变换离子回旋谐振(FT-ICR)质谱法鉴定了在光降解CBZ期间产生的各种芳香族/脂族中间体,并且提出了可能的多步骤降解途径。总体而言,使用5%Ag2O / P-25光催化剂去除PHACs在真正的废水中显示有希望的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号